发明人马晓峰,朱建伟,刘建华. "一种的合成方法" [P]. 中国发明专利, 专利号 CN 115234698 A, 授权公告日 2020-01-20.
发明人何建平,周伟,唐晓军. "Method for the Synthesis of Methyl 1-(4-amino-1,2,5-oxadiazol-3-yl)-5-((pyridin-2-ylthio)methyl)-1H-1,2,3-triazole-4-carboxylate" [P]. 中国发明专利, 专利号 CN 115068029 A, 授权公告日 2021-06-19.
发明人郑宇鹏,赵玉洁,沈红梅. "A Process for Preparing High-Purity Methyl 1-(4-amino-1,2,5-oxadiazol-3-yl)-5-((pyridin-2-ylthio)methyl)-1H-1,2,3-triazole-4-carboxylate" [P]. 中国发明专利, 专利号 CN 116583522 A, 授权公告日 2025-01-09.
参考文献 Literature
Yang F, Sun W, Liu J. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Food Chem., 2025, 755, (3), 928-952.
Yamamoto K, Tanaka H, Suzuki T. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Agric. Food Chem., 2021, 1553, (11), 6005-6011.
Zhou X P, Huang L, Wu G. "Identification and Structural Characterization of a Novel Degradation Product of Methyl 1-(4-amino-1,2,5-oxadiazol-3-yl)-5-((pyridin-2-ylthio)methyl)-1H-1,2,3-triazole-4-carboxylate Using HRMS and NMR". Rapid Commun. Mass Spectrom., 2024, 1870, 4643-4656.
Kumar A, Sharma P, Patel R S. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Pharm. Biomed. Anal., 2013, 2296, (8), 8599-8615.